Fennec Pharmaceuticals (FRX) News Today C$5.65 -0.45 (-7.38%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Wedbush Cuts Earnings Estimates for Fennec PharmaceuticalsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Wedbush decreased their FY2025 earnings per share (EPS) estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Thursday, November 7th. Wedbush analyst D. Nierengarten now forecasts that the biopharmacNovember 11, 2024 | marketbeat.comFennec Pharmaceuticals (FENC) Gets a Buy from Craig-HallumNovember 7, 2024 | markets.businessinsider.comFennec Pharmaceuticals (FRX) Scheduled to Post Quarterly Earnings on ThursdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Crosses Below 50-Day Moving Average - Time to Sell?Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below Fifty Day Moving Average - Time to Sell?October 29, 2024 | marketbeat.comFennec announces three executive appointmentsOctober 29, 2024 | markets.businessinsider.comCapital One Financial Estimates TSE:FRX Q3 EarningsFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Capital One Financial increased their Q3 2024 earnings estimates for shares of Fennec Pharmaceuticals in a note issued to investors on Wednesday, October 16th. Capital One Financial analyst N. Quibria now forecasts that the biopharmaceutical cOctober 21, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low - Should You Sell?Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low - What's Next?October 8, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Rostislav Christov Raykov Sells 2,431 SharesOctober 5, 2024 | insidertrades.comRostislav Christov Raykov Sells 2,431 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of C$6.67, for a total transaction of C$16,212.34.October 4, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month Low at $7.00Fennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $7.00September 23, 2024 | marketbeat.comFennec Pharmaceuticals Inc. (TSE:FRX) Director Sells C$18,115.81 in StockSeptember 7, 2024 | insidertrades.comInsider Selling: Fennec Pharmaceuticals Inc. (TSE:FRX) Director Sells 2,431 Shares of StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Director Rostislav Christov Raykov sold 2,431 shares of the business's stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of C$7.45, for a total transaction of C$18,115.81.September 6, 2024 | marketbeat.comFennec Pharmaceuticals Inc.September 5, 2024 | wsj.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.25Fennec Pharmaceuticals (TSE:FRX) Stock Passes Below Fifty Day Moving Average of $8.25September 3, 2024 | marketbeat.comCantor Fitzgerald Weighs in on Fennec Pharmaceuticals Inc.'s FY2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Equities research analysts at Cantor Fitzgerald cut their FY2024 EPS estimates for Fennec Pharmaceuticals in a note issued to investors on Thursday, August 22nd. Cantor Fitzgerald analyst C. Duncan now expects that the biopharmaceutical companAugust 26, 2024 | marketbeat.comFennec Pharmaceuticals Inc (FRX)August 16, 2024 | investing.comFennec Pharmaceuticals (TSE:FRX) Sets New 12-Month Low at $7.49Fennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $7.49August 14, 2024 | marketbeat.comFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateAugust 14, 2024 | finanznachrichten.deFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2024 Earnings Call TranscriptAugust 14, 2024 | msn.comResearch Analysts Offer Predictions for Fennec Pharmaceuticals Inc.'s Q2 2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Capital One Financial cut their Q2 2024 earnings estimates for shares of Fennec Pharmaceuticals in a research note issued to investors on Monday, August 5th. Capital One Financial analyst N. Quibria now expects that the biophAugust 8, 2024 | marketbeat.comFennec Pharmaceuticals (FRX) to Release Earnings on TuesdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Tuesday, August 13, Zacks reports.August 7, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50-Day Moving Average of $8.89Fennec Pharmaceuticals (TSE:FRX) Share Price Crosses Below Fifty Day Moving Average of $8.89August 6, 2024 | marketbeat.comFennec Pharma Names Hackman CEOAugust 5, 2024 | markets.businessinsider.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $8.16Fennec Pharmaceuticals (TSE:FRX) Reaches New 12-Month Low at $8.16July 3, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Sets New 1-Year Low at $8.41Fennec Pharmaceuticals (TSE:FRX) Reaches New 52-Week Low at $8.41June 26, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 52-Week Low at $8.93Fennec Pharmaceuticals (TSE:FRX) Hits New 12-Month Low at $8.93June 20, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Stock Price Crosses Below 50 Day Moving Average of $11.14Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving Average of $11.14June 20, 2024 | marketbeat.comQ2 2024 EPS Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX) Reduced by Capital One FinancialFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Analysts at Capital One Financial dropped their Q2 2024 earnings per share (EPS) estimates for Fennec Pharmaceuticals in a report issued on Monday, June 10th. Capital One Financial analyst N. Quibria now anticipates that the biopharmaceuticalJune 12, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Hits New 1-Year Low at $9.00Fennec Pharmaceuticals (TSE:FRX) Hits New 1-Year Low at $9.00June 3, 2024 | marketbeat.comFY2024 EPS Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX) Lowered by Cantor FitzgeraldFennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Stock analysts at Cantor Fitzgerald lowered their FY2024 earnings estimates for Fennec Pharmaceuticals in a research report issued on Wednesday, May 15th. Cantor Fitzgerald analyst C. Duncan now forecasts that the biopharmaceutical company wilMay 17, 2024 | marketbeat.comQ4 2025 Earnings Forecast for Fennec Pharmaceuticals Inc. Issued By HC Wainwright (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - HC Wainwright lifted their Q4 2025 earnings estimates for Fennec Pharmaceuticals in a note issued to investors on Wednesday, May 15th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings per sMay 16, 2024 | marketbeat.comFennec Pharmaceuticals (TSE:FRX) Sets New 52-Week Low at $9.00Fennec Pharmaceuticals (TSE:FRX) Hits New 12-Month Low at $9.00May 14, 2024 | marketbeat.comFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 14, 2024 | finanznachrichten.deFennec Pharmaceuticals (FRX) to Release Quarterly Earnings on TuesdayFennec Pharmaceuticals (TSE:FRX) will be releasing earnings before the market opens on Tuesday, May 14, Zacks reports.May 8, 2024 | marketbeat.comAdrian J. Haigh Sells 22,223 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockApril 24, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Acquires 22,222 SharesApril 17, 2024 | insidertrades.comAdrian J. Haigh Buys 22,222 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockFennec Pharmaceuticals Inc. (TSE:FRX - Get Free Report) Senior Officer Adrian J. Haigh purchased 22,222 shares of the firm's stock in a transaction that occurred on Monday, April 15th. The stock was bought at an average cost of C$2.31 per share, for a total transaction of C$51,332.82.April 16, 2024 | marketbeat.comInsider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)April 5, 2024 | finance.yahoo.comFRX:CA Fennec Pharmaceuticals Inc.April 1, 2024 | seekingalpha.comChris Anigeron Rallis Sells 2,114 Shares of Fennec Pharmaceuticals Inc. (TSE:FRX) StockMarch 31, 2024 | insidertrades.comFennec Pharmaceuticals Inc. (FENC) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | seekingalpha.comFennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | finance.yahoo.comWedbush Comments on Fennec Pharmaceuticals Inc.'s Q3 2024 Earnings (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush decreased their Q3 2024 earnings per share estimates for Fennec Pharmaceuticals in a research report issued on Thursday, March 21st. Wedbush analyst D. Nierengarten now expects that the biopharmaceutical company wiMarch 22, 2024 | marketbeat.comFennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business UpdateMarch 21, 2024 | finanznachrichten.deWedbush Research Analysts Cut Earnings Estimates for Fennec Pharmaceuticals Inc. (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush dropped their FY2024 EPS estimates for Fennec Pharmaceuticals in a research note issued to investors on Monday, March 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharmaceutical company will poMarch 20, 2024 | marketbeat.comStocks in play: Fennec Pharmaceuticals Inc.March 19, 2024 | ca.finance.yahoo.comFennec Pharmaceuticals Inc. to Post Q2 2024 Earnings of $0.12 Per Share, Wedbush Forecasts (TSE:FRX)Fennec Pharmaceuticals Inc. (TSE:FRX - Free Report) - Research analysts at Wedbush cut their Q2 2024 earnings per share estimates for Fennec Pharmaceuticals in a research report issued to clients and investors on Monday, March 18th. Wedbush analyst D. Nierengarten now anticipates that the biopharMarch 19, 2024 | marketbeat.comFennec, Norgine Reach Licensing Deal To Commercialize Pedmarqsi In Europe, Australia, & New ZealandMarch 17, 2024 | markets.businessinsider.comFennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 ResultsFebruary 29, 2024 | finance.yahoo.comFENC Mar 2024 10.000 callFebruary 23, 2024 | finance.yahoo.com Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Free Cheat Sheet: Build a Dividend Portfolio (Ad)Have you ever wanted to build your own, custom dividend portfolio? A well-rounded portfolio of high quality dividend stocks that produce passive cash flow is one of the best ways to build your nest egg. And, according to one expert, you can do it with a very straightforward process too! These FIVE (FREE) Dividend Investing Cheatsheets Show you How! FRX Media Mentions By Week FRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FRX News Sentiment▼-0.410.56▲Average Medical News Sentiment FRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FRX Articles This Week▼41▲FRX Articles Average Week Get Fennec Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for FRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SLS News Today AIM News Today APM News Today CRDL News Today GXE News Today ITH News Today MDNA News Today GPH News Today EQ News Today ME News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:FRX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
